← Back to Search

RelieVRx headset for Knee Arthropathy

N/A
Waitlist Available
Led By Dr. Michael Suk
Research Sponsored by AppliedVR Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will study whether the appliedVR headset can help relieve pain for those undergoing total knee surgery, and whether it can help reduce dependence on opioids.

Eligible Conditions
  • Knee Arthropathy
  • Opioid Use Disorder
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Postoperative Pain
Opioid Consumption
Secondary outcome measures
KOOS Jr. Score
Veterans RAND 12 Health Survey (VR-12) - Physical Component Score

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of care + RelieVRx groupExperimental Treatment2 Interventions
Receive standard of care for pain management, plus RelieVRx headset
Group II: Standard of care groupActive Control1 Intervention
Receive standard of care for pain management, do not receive RelieVRx headset
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
multi-modality pain management
2021
N/A
~70
RelieVRx headset
2021
N/A
~70

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,570 Total Patients Enrolled
AppliedVR Inc.Lead Sponsor
10 Previous Clinical Trials
3,008 Total Patients Enrolled
Geisinger ClinicOTHER
148 Previous Clinical Trials
1,886,030 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use
2021. "RelieVRx for Total Knee Arthroplasty (TKA) for the Reduction of Acute Postoperative Pain and Opioid Use". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04010266.
~15 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top